Andover Eye Associates
Andover, Massachusetts, 01810, United States
NCT Number: NCT01547936
The purpose of this study is to evaluate the effect of the controlled adverse environment (CAE) on Mean Break-Up Area in subjects diagnosed with Dry Eye Syndrome.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Andover, Massachusetts, 01810, United States
Single-Center, Pilot, controlled adverse environment (CAE) Study.
This is a single-center, one visit, pilot, CAE study. Dry Eye Subjects (N=30) who qualify will undergo tear film video recording, fluorescein staining, and break up time before CAE exposure and after CAE exposure.
All subjects will undergo baseline dry eye assessments including fluorescein staining, breakup time, conjunctival redness and tear film video recording. Subjects who qualify will then undergo CAE exposure for 90 minutes. At the end of CAE exposure subjects will undergo dry eye assessments again.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: change from baseline in tear film break up area at 30 minutes post-CAE at study visit
Time frame: change from baseline in staining at 30 minutes post-CAE
Time frame: change from baseline in tear film break up time at 30 minutes post-CAE
Time frame: change from baseline in conjunctival redness at 30 minutes post-CAE
ORA, Inc.
Industry
A Single-Center Study Evaluating the Effect of the Controlled Adverse Environment (CAE) on Tear Film Stability Using the OPI 2.0 System, Ocular Protection Index (OPI), Tear Film Break-Up Time (TFBUT) and Mean Break up Area by Region (MBA) in Patients Diagnosed With Dry Eye Evaluated During Their Natural Blink Pattern
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00201955
Conjunctival Diseases, Conjunctivitis
Birmingham, Alabama, United States
View Trial DetailsNCT00201981
Conjunctival Diseases, Conjunctivitis
Birmingham, Alabama, United States
View Trial DetailsNCT07422259
Conjunctival Diseases, Conjunctivitis
Messina, Italy
View Trial DetailsNCT03953703
Arthritis, Arthritis, Rheumatoid
Nashville, Tennessee, United States
View Trial Details